Results and presentations

Latest results announcements and presentations


General Investor Presentation

1 download available


AstraZeneca Investor Science Event at ERS 2017

1 Download available

AstraZeneca Investor Science Event at ESMO 2017

1 Download available



Majority stake investment in Acerta Pharma

2 Downloads available

Late-stage pipeline call

1 Download available

American College of Rheumatology (ACR) 2015 Investor science conference call

2 Downloads available

Acquisition of ZS Pharma

1 Download available


European Society for Medical Oncology (ESMO) 2014

3 Downloads available



Fostamatinib analyst briefing

2 Downloads available

Fostamatinib analyst briefing video

Play Video

Naloxegol educational presentation

2 Downloads available

Naloxegol educational presentation video

Play Video

R&D Roundtable

1 Download available

30th Annual J.P. Morgan Healthcare Conference

1 Download available

Upcoming events

Payment date: first interim dividend

Year-to-date and Q3 2018 Results

SEC filings

SEC filings are those documents that we are required to file by virtue of our listing on the New York Stock Exchange. They contain mainly financial information.

These documents are also available for viewing on the SEC website at The Company will send any holder of the Company’s securities, upon request, a hard copy of the Company’s complete audited financial statements free of charge. Requests may be made by writing to:

Company Secretary
AstraZeneca PLC
1 Francis Crick Avenue
Cambridge Biomedical Campus
Cambridge CB2 0AA

Annual reports

Investor enquiries

Main Contacts

Thomas Kudsk Larsen

Josie Afolabi


Craig Marks

Finance, Fixed Income

Henry Wheeler


Nick Stone

Respiratory; Renal

Christer Gruvris

Cardiovascular, Metabolism

Jennifer Kretzmann

Retail Investors

US general enquiries